Trabectedin improves patients with drug resistant metastatic leiomyosarcoma #SGOmtg

Martee L. Hensley, MD of Memorial Sloan Kettering discusses trabectedin improves patients with drug resistant metastatic leiomyosarcoma at SGO 2016. Author: sgo2016 Added: 03/23/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts